Meet The Team

Dr John Lloyd
Director

john.lloyd@script-ip.com
+44 (0) 1373 753 010

Academic and Research Background

After his PhD, John moved to the Dyson Perrins Laboratory at the University of Oxford, UK where he undertook post-doctoral research in the group of Professor Sir Jack Baldwin FRS. He moved on to work at Cytocell Ltd as a research scientist where he developed isothermal nucleic acid amplification technologies.

Professional Experience

John joined the patent profession in 2000. He began his career at D Young & Co. where he trained and qualified as a Patent Attorney. He was a Partner in an international law firm and another firm of patent attorneys before joining Script IP.

John's clients have included universities, early stage companies and SMEs, as well as very well-known biotechnology, healthcare and medical device companies. He therefore has experience of the differing requirements of clients which adds an interesting layer of diversity to his practice.

His skills also extend to opposition and appeal proceedings and oral proceedings before the European Patent Office. He has recently enjoyed a successful spell in EPO opposition proceedings defending three different patents and maintaining all of them as granted. He also provides patentability, non-infringement and freedom to operate opinions for his clients.

Selected technical publications include:

US Patent No. 7,005,261: "Method for detecting nucleic acid target sequences involving in vitro transcription from an RNA polymerase promoter".

WO2001/009376: "Method for amplification of nucleic acids".

"X-ray crystal structure of Escherichia coli Taurine/a-ketoglutarate dioxygenase complexed to ferrous iron and substrate(s)" Biochemistry, 2002, 41, 5185-5192.

"Specific detection of DNA and RNA targets using a novel isothermal nucleic acid amplification assay based on the formation of a three-way junction structure" Nucleic Acids Research, 2001, 29 e54.

"Homologous expression of soluble methane monooxygenase genes in Methylosinus trichosporium OB3b" Microbiology, 1999 Feb; 145 ( Pt 2):461-70.

"Heterologous expression of soluble methane monooxygenase genes in methanotrophs containing only particulate methane monooxygenase" Archives of Microbiology, 1999, 171(6), 364-70.

"Heterologous expression of alkene monooxygenase from Rhodococcus rhodochrous B-276" European Journal of Biochemistry, 1999, 260(2), 446-52.

"Inactivation of the Regulatory Protein B of Soluble Methane Monooxygenase from Methylococcus capsulatus (Bath) by Proteolysis can be Overcome by a Gly to Gln Modification" European Journal of Biochemistry, 1999, 248, 72-79.

Memberships

  • Member of European Patent Institute (epi)
  • Fellow of the Chartered Institute of Patent Attorneys

Qualifications

  • European Patent Attorney
  • UK Patent Attorney
  • European Design Attorney
  • Post graduate certificate in IP, University of London, UK
  • PhD in Molecular Biology, University of Warwick, UK
  • First Class Honours Degree in Microbiology, King’s College London, UK

Expertise

  • Life Sciences/Biotechnology
  • Molecular biology
  • Microbiology
  • Nucleic acid technologies
  • Molecular diagnostics
  • Medical devices
  • Analytical instrumentation
  • EPO Oppositions in Life Sciences/Biotechnology and Medical Devices

Beyond John’s technical understanding of our technology he is able to quickly tailor his advice into sound business strategy to meet the commercial objectives of our business. That is very valuable.

Jeff Landes, Senior Patent Counsel, Hologic: Gen-Probe Incorporated